474 results
8-K
EX-99.1
AORT
Artivion Inc
30 Oct 12
Results of Operations and Financial Condition
12:00am
to litigation expense. Excluding these charges, proforma non-GAAP earnings per share would have been $0.08 in the third quarter of 2012. Net income … for the third quarter of 2011 included $1.1 million in costs related to business development and integration, and $881,000 related to litigation expenses
8-K
EX-99.1
AORT
Artivion Inc
29 Jul 10
Results of Operations and Financial Condition
12:00am
executive officer.
The Company recorded pretax charges in the second quarter of 2010 of approximately $420,000 in costs related to litigation with Medafor … $834,000 in costs related to litigation with Medafor. Additionally, the Company recorded a $1.2 million gain on valuation of the derivative related
8-K
EX-10
AORT
Artivion Inc
5 Aug 05
Entry into a Material Definitive Agreement
12:00am
STATE OF GEORGIA
- ---------------------------------------------
In re CRYOLIFE, INC. DERIVATIVE LITIGATION … of record in the Litigation; and (ii) the Defendants
identified below, by and through their counsel of record in the Litigation. The
Stipulation
8-K
EX-99.1
AORT
Artivion Inc
31 Jul 12
Results of Operations and Financial Condition
12:00am
with acquisition of Hemosphere
Settled all significant outstanding litigation
ATLANTA, GA – (July 31, 2012) – CryoLife, Inc. (NYSE: CRY), a leading tissue … for the HeRO Graft and our existing CryoVein® and CryoArtery® preserved human tissues. On the legal front, our completed settlements for outstanding litigation
8-K
EX-99.1
AORT
Artivion Inc
16 Jan 07
CryoLife Announces Preliminary Fourth Quarter 2006 Revenues of Approximately $21 Million
12:00am
the Company's continued execution of its corporate strategy, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act … its business, that pending litigation cannot be settled on terms acceptable to the Company, that the Company may not have sufficient resources to pay
8-K
EX-99.1
rno3jb81 zg9t93sbx1j
5 Aug 03
Financial statements and exhibits
12:00am
8-K
EX-99.1
d8muth sj6
14 Feb 13
Results of Operations and Financial Condition
12:00am
8-K
EX-99.2
kz9fhn omj3p9
20 Dec 06
Entry into a Material Definitive Agreement
12:00am
8-K/A
EX-99.1
77agj9wq1f9u
23 Feb 15
Results of Operations and Financial Condition
12:00am
425
yfohhiyywkqv1
11 Mar 10
Business combination disclosure
12:00am
8-K
EX-99.1
2jw fgmg3b45g
26 Apr 12
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
6vo14
19 Jan 06
Other Events
12:00am
8-K
EX-99.1
t1a4t2k
29 Oct 13
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
nyactrl2ejq2dy7
16 Feb 12
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
qsrjgr846dt
28 Oct 14
Results of Operations and Financial Condition
12:00am